Abstract
The aim of this investigation was to develop hydrocortisone butyrate (HB)-loaded poly(d,l-lactic-co-glycolic acid) (PLGA) nanoparticles (NP) with ideal encapsulation efficiency (EE), particle size, and drug loading (DL) under emulsion solvent evaporation technique utilizing various experimental statistical design modules. Experimental designs were used to investigate specific effects of independent variables during preparation of HB-loaded PLGA NP and corresponding responses in optimizing the formulation. Plackett–Burman design for independent variables was first conducted to prescreen various formulation and process variables during the development of NP. Selected primary variables were further optimized by central composite design. This process leads to an optimum formulation with desired EE, particle size, and DL. Contour plots and response surface curves display visual diagrammatic relationships between the experimental responses and input variables. The concentration of PLGA, drug, and polyvinyl alcohol and sonication time were the critical factors influencing the responses analyzed. Optimized formulation showed EE of 90.6%, particle size of 164.3 nm, and DL of 64.35%. This study demonstrates that statistical experimental design methodology can optimize the formulation and process variables to achieve favorable responses for HB-loaded NP.
Similar content being viewed by others
References
Gambrill J, Miller L. Topical corticosteroids. Aust Fam Physician. 1984;13(1):45–7.
Lundberg IE, Grundtman C, Larsson E, Klareskog L. Corticosteroids—from an idea to clinical use. Best Pract Res Clin Rheumatol. 2004;18(1):7–19.
Oren D, Nulman I, Makhija M, Ito S, Koren G. Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? Can Fam Physician. 2004;50:1083–5.
Fini A, Bergamante V, Ceschel GC, Ronchi C, De Moraes CA. Control of transdermal permeation of hydrocortisone acetate from hydrophilic and lipophilic formulations. AAPS PharmSciTech. 2008;9(3):762–8.
Griffiths CE, Van Leent EJ, Gilbert M, Traulsen J, Cipamyflline Study Group. Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis. Br J Dermatol. 2002;147(2):299–307.
Hydrocortisone eye drops and ointment. http://www.netdoctor.co.uk/eyes/medicines/hydrocortisone-eye-drops.html.
Laval J. Use of hydrocortisone (hydrocortone) acetate in ophthalmology. AMA Arch Ophthalmol. 1953;50(3):299–302.
Shimo T, Yamazaki M, Noguchi Y, Mukawa A, Kato H, Ito Y. Irritation test of dexamethasone valerate (DV-17) and other steroid ointments in rabbits. Skin and eye primary irritation tests, and skin cumulative irritation test. J Toxicol Sci. 1982;7 Suppl 1:1–13. Japanese.
Komatsu A, Ohashi K, Oba H, Kakehashi T, Mizushima Y, Shirasawa E, et al. Application of lipid microsphere drug delivery system to steroidal ophthalmic preparation. Jpn J Ophthalmol. 1988;32(1):41–3.
Wilkinson SM, English JS. Hydrocortisone sensitivity: a prospective study of the value of tixocortol pivalate and hydrocortisone acetate as patch test markers. Contact Dermatitis. 1991;25(2):132–3.
Umer S. Bioavailability of hydrocortisone acetate from ophthalmic ointments. Acta Pol Pharm. 1994;51(1):39–43.
Sejpal P, Scott-Weideman J. Surgical intervention of steroid-induced ocular hypertension from Ozurdex. Optom Vis Sci. 2013;90(1):e24–30.
Bollinger K, Kim J, Lowder CY, Kaiser PK, Smith SD. Intraocular pressure outcome of patients with fluocinolone acetonide intravitreal implant for noninfectious uveitis. Ophthalmology. 2011;118(10):1927–31.
Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev. 1997;28(1):5–24.
Mei L, Sun H, Jin X, Zhu D, Sun R, Zhang M, et al. Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model. Pharm Res. 2007;24(5):955–62.
Singh B, Kumar R, Ahuja N. Optimizing drug delivery systems using systematic “design of experiments.” Part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst. 2005;22(1):27–105.
Singh B, Dahiya M, Saharan V, Ahuja N. Optimizing drug delivery systems using systematic “design of experiments.” Part II: retrospect and prospects. Crit Rev Ther Drug Carrier Syst. 2005;22(3):215–94.
Kenari HS, Alinejad Z, Imani M, Nodehi A. Effective parameters in determining cross-linked dextran microsphere characteristics: screening by Plackett–Burman design-of-experiments. J Microencapsul. 2013;30(6):599–611.
Tasharrofi N, Adrangi S, Fazeli M, Rastegar H, Khoshayand MR, Faramarzi MA. Optimization of chitinase production by Bacillus pumilus using Plackett–Burman design and response surface methodology. Iran J Pharm Res. 2011;10(4):759–68.
Rambali B, Baert L, Thoné D, Massart DL. Using experimental design to optimize the process parameters in fluidized bed granulation. Drug Dev Ind Pharm. 2001;27(1):47–55.
Hibbert DB. Experimental design in chromatography: a tutorial review. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;910:2–13.
Antony J. Design of experiments for engineers and scientists. 1st ed. Amsterdam: Elsevier; 2003.
Keum CG, Noh YW, Baek JS, Lim JH, Hwang CJ, Na YG, et al. Practical preparation procedures for docetaxel-loaded nanoparticles using polylactic acid-co-glycolic acid. Int J Nanomedicine. 2011;6:2225–34.
Box GEP, Hunter JS, Hunter WG. Statistics for experimenters: design, innovation, and discovery. 2nd ed. New York: Wiley; 2005.
Rekab K, Shaikh M. Statistical design of experiments with engineering applications. Florida: Taylor & Francis; 2005.
Kang LS, Trinh TK. Application of response surface method as an experimental design to optimize coagulation tests. Environ Eng Res. 2010;15(2):63–70.
Montgomery DC. Design and analysis of experiments. 4th ed. New York: Wiley; 1997.
McCarron PA, Woolfson AD, Keating SM. Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles. Int J Pharm. 1999;193(1):37–47.
Analytical Methods Committee. AMCTB No 55. Experimental design and optimisation (4): Plackett–Burman designs. Anal Methods. 2013;5:1901–3.
Demirel M, Kayan B. Application of response surface methodology and central composite design for the optimization of textile dye degradation by wet air oxidation. Int J Ind Chem. 2012;3:24.
Montegometry DC. Introduction to factorial designs. Design and analysis of experiments. New York: Wiley; 2004. p. 392–426.
Montgometry DC. Design and analysis of experiments. 7th ed. New York: Wiley; 2008.
Akhnazarova S, Kafaro V. Experiment optimization in chemistry and chemical engineering. Moscow: Mir House Publicaions; 1982.
Box GEP, Wilson KB. On the experimental attainment of optimum conditions. J R Stat Soc B. 1951;B13:1–45.
Bryc W. The normal distribution. Characterization with applications. Lecture notes in statistics, vol. 100. New York: Springer; 1995.
Acknowledgments
This work was supported by a Missouri Life Sciences Research grant (no. MLSRB0017025) and National Institutes of Health grants (R01 EY 10659-12).
Author Disclosure Statement
No completing financial interests exist.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, X., Patel, S., Sheng, Y. et al. Statistical Design for Formulation Optimization of Hydrocortisone Butyrate-Loaded PLGA Nanoparticles. AAPS PharmSciTech 15, 569–587 (2014). https://doi.org/10.1208/s12249-014-0072-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-014-0072-4